Cannabis Extract Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Extract Type, Sources, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Cannabis Extract Market size stood at USD 7.7 billion in 2026 and is predicted to grow at a 19% CAGR from 2027 to 2036, reaching USD 43.85 billion by 2036. The industry revenue for 2027 is calculated at USD 8.93 billion.
Get more details on this report
Request Free Sample ReportCannabis Extract Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 75.36% market share in 2026, supported by mature licensed cultivation, standardized extraction, established retail channels, and strong medical and adult-use product demand.
- Europe is projected to grow at a 22.18% CAGR, driven by expanding medical cannabis access, stronger physician acceptance, regulated supply development, and increasing demand for standardized extract formulations.
Segment Momentum
- Oils accounted for 60.92% of the market in 2026 because they provide formulation flexibility, standardized dosing, and broad compatibility across medical, wellness, and consumer product applications.
- Full Spectrum Extracts held a 67.87% share in 2026 while remaining the fastest-growing extract type due to strong demand for products retaining a broader range of plant compounds across multiple formulations.
Market Expansion Drivers
- Expansion of medical cannabis legalization supporting therapeutic extract adoption.
- Rising chronic disease burden increasing demand for cannabis-based therapies.
- Product innovation in CBD oils and tinctures expanding pharmaceutical integration.
Leading Market Participants
- Key players in the cannabis extract market include Canopy Growth Corporation (Canada), Tilray Brands, Inc. (Canada), Aurora Cannabis Inc. (Canada), Cronos Group Inc. (Canada), Organigram Holdings Inc. (Canada), Tikun Olam Ltd. (Israel), Curaleaf Holdings, Inc. (United States), Green Thumb Industries Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 7.7 billion
- 2027 Estimated Market Size: USD 8.93 billion.
- Projected Market Size: USD 43.85 billion by 2036
- Growth Forecast: 19% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Europe
- Core Revenue Segment: Oils (Product Type) | Full Spectrum Extracts (Extract Type) | Marijuana (Sources) | Medical Use (End-use)
- Emerging Opportunity Segment: Oils (Product Type) | Full Spectrum Extracts (Extract Type) | Marijuana (Sources) | Medical Use (End-use)
Market Growth Drivers and Industry Trends
Expansion of medical cannabis legalization supporting therapeutic extract adoption
Broader legalization of medical cannabis will drive the cannabis extract market by creating a more established regulatory pathway for therapeutic extract use. As medical applications gain formal recognition, healthcare-related demand can expand for standardized cannabis-derived formulations, while greater legal acceptance supports wider integration of extracts into therapeutic practices and regulated product channels.
Rising chronic disease burden increasing demand for cannabis-based therapies
A growing chronic disease burden will propel the cannabis extract market as patients and healthcare providers increasingly consider cannabis-based therapies as part of treatment approaches. Demand for therapeutic extracts can rise as chronic conditions create sustained requirements for symptom management and other cannabis-related applications, encouraging greater utilization of extract-based products in medical settings.
Product innovation in CBD oils and tinctures expanding pharmaceutical integration
Innovation across CBD oils and tinctures is strengthening the cannabis extract market by broadening the range of extract formats available for therapeutic use. Improvements in product development can support more consistent and convenient formulations, making cannabis-derived ingredients easier to incorporate into pharmaceutical and healthcare-oriented applications while expanding opportunities for regulated extract-based products.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising legalization and medical adoption of cannabis extracts | 7.00% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Expansion in recreational cannabis markets | 6.00% | Medium term (2–5 yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Moderate |
| Technological advancements in extraction and formulation | 6.80% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Slow |
| Expansion of medical cannabis legalization supporting therapeutic extract adoption | 2.70% | High | North America, Europe | High | Near Term |
| Rising chronic disease burden increasing demand for cannabis-based therapies | 2.20% | High | North America, Middle East & Africa | High | Mid Term |
| Product innovation in CBD oils and tinctures expanding pharmaceutical integration | 1.90% | Moderate | North America, Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the cannabis extract market, North America held the largest share of 75.36% in 2026, supported by established cannabis processing infrastructure, broad product availability, and comparatively mature regulatory frameworks across major markets. The region benefits from strong consumer demand for cannabis-derived oils, concentrates, and other formulated extracts across wellness, therapeutic, and recreational applications. Growing product diversification, improvements in extraction and purification technologies, and increasing emphasis on standardized formulations are strengthening commercial opportunities. Investment in processing capabilities and evolving regulatory acceptance are also encouraging the development of higher-value extracts with greater consistency and targeted applications.
Europe (Fastest-Growing Region)
Europe is emerging as the fastest-growing regional market, supported by the gradual expansion of regulated medical cannabis programs and increasing interest in cannabinoid-based therapeutic products. Greater healthcare-sector engagement with cannabis-derived treatments, improving regulatory clarity, and rising consumer awareness are creating favorable conditions for extract adoption. The region is also seeing increasing attention toward quality control, pharmaceutical-grade processing, and traceability, which can support the transition toward more standardized extract products. Expanding research into cannabinoid applications and the development of regulated distribution channels are expected to further reinforce Europe’s growth trajectory.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Medical Cannabis ExpansionGermany's cannabis extract market is increasingly oriented toward pharmaceutical and therapeutic applications supported by evolving healthcare acceptance. German stakeholders are emphasizing standardized extracts and quality-controlled production suitable for prescription-based medical use.
France 🇫🇷
Pharmaceutical Evaluation PathwayFrance is assessing cannabis extracts through medical and clinical frameworks, encouraging interest in standardized formulations and patient access programs. The French market is prioritizing evidence-based applications and controlled distribution mechanisms for cannabis-derived products.
Italy 🇮🇹
Specialty Extract ApplicationsItaly's cannabis extract market is supported by demand for medically oriented formulations and specialized therapeutic products. Companies in Italy are focusing on extraction quality, product consistency, and compliance with pharmaceutical-grade manufacturing requirements.
Japan 🇯🇵
Research-Oriented DevelopmentJapan remains focused on research and regulatory assessment of cannabis-derived compounds rather than broad commercial adoption. Interest in Japan is centered on extracts with potential pharmaceutical applications and scientifically validated therapeutic properties.
South Korea 🇰🇷
Controlled Therapeutic AccessSouth Korea maintains a tightly regulated environment where cannabis extracts are primarily considered for specific medical applications. Market activity in South Korea is concentrated on compliant import channels and carefully supervised therapeutic use cases.
United States 🇺🇸
Product Diversification CenterThe U.S. cannabis extract market benefits from broad product innovation across medical and wellness applications. Companies in the U.S. are expanding extraction capabilities and developing differentiated formulations, including concentrates, tinctures, and ingredient-based consumer products.
Segment Leadership and Growth Trends
Cannabis Extract Market Share (%), by Product Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Oils (Largest & Fastest-Growing Segment)
Oils led the cannabis extract market, holding a 60.92% share in 2026, while also representing the fastest-growing product type. Their leading position is supported by formulation flexibility and their ability to be incorporated into a variety of consumer and wellness-oriented products. Oil-based extracts can be blended into different formulations and offer convenient handling, making them attractive for manufacturers developing differentiated extract-based products. Continued interest in extract formats that provide ease of formulation and consistent product characteristics is expected to sustain strong demand for cannabis oils.
Extract Type Segment Analysis: Full Spectrum Extracts (Largest & Fastest-Growing Segment)
Full spectrum extracts accounted for the largest share of the cannabis extract market, with a 67.87% share in 2026, and are also the fastest-growing extract type. Their appeal stems from retaining a broader range of naturally occurring compounds from the cannabis plant compared with more selectively refined extract formats. This characteristic supports demand among consumers and manufacturers seeking extract products that maintain a more comprehensive plant profile. Increasing product diversification and continued interest in minimally processed extract formats are further supporting adoption of full spectrum extracts across the industry.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Oils, Tinctures | Oils | Oils |
| Extract Type | Full Spectrum Extracts, Cannabis Isolates | Full Spectrum Extracts | Full Spectrum Extracts |
| Sources | Hemp, Marijuana | Marijuana | Marijuana |
| End-use | Medical Use, Recreational Use | Medical Use | Medical Use |
Competitive Landscape and Market Positioning
Top players in the cannabis extract market:
1. Canopy Growth Corporation (Canada)
2. Tilray Brands Inc. (Canada)
3. Aurora Cannabis Inc. (Canada)
4. Cronos Group Inc. (Canada)
5. Organigram Holdings Inc. (Canada)
6. Tikun Olam Ltd. (Israel)
7. Curaleaf Holdings Inc. (United States)
8. Green Thumb Industries Inc. (United States)
In the cannabis extract market, evolving regulatory frameworks are shaping product standardization and safety requirements. Innovation is focused on improving extraction purity and consistency. The cannabis extract market is also witnessing diversification in therapeutic and wellness applications. Research efforts are supporting improved formulation stability and efficacy.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Canopy Growth Corporation (Canada) | |||||||
| Tilray Brands Inc. (Canada) | |||||||
| Aurora Cannabis Inc. (Canada) | |||||||
| Cronos Group Inc. (Canada) | |||||||
| Organigram Holdings Inc. (Canada) | |||||||
| Tikun Olam Ltd. (Israel) | |||||||
| Curaleaf Holdings Inc. (United States) | |||||||
| Green Thumb Industries Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Artrix | Apr-26 | Artrix introduced "Glassic," a specialized glass vape platform engineered for premium cannabis extracts. The hardware focuses on improving vapor purity and flavor profiles, providing manufacturers with a technical solution to enhance product performance and differentiation within the competitive cannabis extract-based vaping segment. |
| Somai Pharmaceuticals | Feb-26 | Somai Pharmaceuticals is scaling its international footprint, currently operating in 12 countries with plans to expand to 18. This multi-market strategy strengthens the company’s distribution network for regulated cannabis extracts, leveraging regional regulatory approvals and partnerships to capture market share across European and other emerging international medical cannabis sectors. |
| Vertanical | Oct-25 | Vertanical achieved Phase III clinical trial success for its VER-01 cannabis-derived therapy for chronic low back pain. This clinical milestone validates the company’s evidence-based therapeutic pipeline, significantly strengthening its regulatory standing in Europe and providing a foundation for upcoming pivotal clinical studies required for U.S. market entry. |
| Demecan | Jul-25 | Demecan launched "FE 800 No.1," the first German-produced cannabis extract utilizing live rosin extraction technology. This innovation introduces premium extraction standards to the German medical cannabis market, signaling a shift toward higher-quality, fresh-processed products within the regulated supply chain and reinforcing the company’s competitive position in the region. |
| Exka Inc | May-25 | Health authorities issued a recall for Exka Inc.’s cannabis extract products in Quebec due to defective child-resistant packaging. This development underscores the stringent regulatory requirements governing cannabis distribution and highlights the operational risks manufacturers face regarding packaging compliance and supply chain safety within legal retail frameworks. |
| Grön | Mar-25 | Grön expanded its portfolio with the launch of 1000mg high-dose infused chocolates across U.S. markets. This rollout reflects a strategic focus on large-format, value-oriented cannabis extract edibles, targeting high-frequency consumers and strengthening the company's competitive presence in the medical and recreational edible segments. |
| Raw Garden | Feb-25 | Raw Garden introduced the "Sprout" vape platform, which utilizes terpene-safe materials to enhance extract purity and hardware sustainability. This development highlights a commitment to improving consumption technology and product integrity, reinforcing the company's position as a premium provider within the cannabis extract hardware ecosystem. |
| Cannazo India | Jul-24 | Cannazo India leveraged national media exposure to showcase its medical cannabis extract innovations targeting multiple sclerosis patients. The initiative represents a strategic move to raise product visibility and commercialize therapeutic cannabis solutions within India's nascent medical cannabis sector, signaling potential for broader consumer acceptance of extract-based medical treatments. |
| Tilray Medical | Mar-24 | Tilray Medical secured regulatory approval in Portugal for its THC 5 / CBD 20 cannabis extract formulation. This authorization facilitates the commercialization of its pharmaceutical-grade products in the Portuguese medical market, strategically bolstering the company’s European cannabis portfolio and expanding its access to regulated medical patient populations. |
| Paul's Boutique | Jan-24 | Paul’s Boutique implemented automation-driven manufacturing improvements to optimize the production of cannabis extracts. By focusing on operational modernization, the company aims to enhance batch consistency and overall process efficiency, setting a benchmark for quality standardization in the production of cannabis-based products. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Cannabis Extract Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Route of Administration | Oral, Sublingual, Inhalation, Topical & Transdermal |
| Distribution Channel | Dispensaries & Cannabis Retailers, Pharmacies & Healthcare Providers, Online Retail, Other Specialty Retail |
| Regulatory Category | Prescription & Pharmaceutical-Grade, Medical Cannabis, Adult-Use Cannabis, Wellness & Consumer Products |
Cannabis Extract Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Regulatory Pathway Assessment Across Key Markets |
|
| Medical Cannabis Adoption Landscape |
|
| Extraction Technology Benchmarking |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the cannabis extract market?
How much is the cannabis extract industry expected to grow by 2036?
How is medical cannabis legalization impacting adoption of cannabis extracts?
Why is rising chronic disease prevalence increasing demand for cannabis extracts?
Why are oils the leading product type in the cannabis extract market?
Why are full spectrum extracts growing rapidly in the cannabis extract market?
Why is North America the largest cannabis extract market?
What is contributing to the rapid growth of the cannabis extract market in Europe?
Which companies are driving growth in the cannabis extract landscape?
Our Clients
"The report provided a thorough look at market trends, technological advancements, and the competitive landscape. The depth of insights was really valuable."
ITC Limited
"We would highly recommend Fundamental Business Insights & Consulting to anyone looking for reliable, detailed, and comprehensive market research in the Food industry."
Tyson Foods
"The clarity and presentation of the information were commendable. The report was delivered timely, which made the overall experience smooth and convenient."
Mondelēz International
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Food & Beverage Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| Food and Agriculture Organization (FAO) | www.fao.org |
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Food Safety Authority (EFSA) | www.efsa.europa.eu |
| U.S. Department of Agriculture (USDA) | www.usda.gov |
| Codex Alimentarius Commission | www.fao.org/fao-who-codexalimentarius |
| International Organization for Standardization (ISO) | www.iso.org |
| AOAC INTERNATIONAL | www.aoac.org |
| Institute of Food Technologists (IFT) | www.ift.org |
| International Dairy Foods Association (IDFA) | www.idfa.org |
| International Sweeteners Association (ISA) | www.sweeteners.org |
| International Probiotics Association (IPA) | internationalprobiotics.org |
| Good Food Institute (GFI) | gfi.org |
| American Feed Industry Association (AFIA) | www.afia.org |
| International Feed Industry Federation (IFIF) | ifif.org |
| Specialty Food Association (SFA) | www.specialtyfood.com |
| Brewers Association | www.brewersassociation.org |
| International Bottled Water Association (IBWA) | bottledwater.org |
| International Alliance for Dietary/Food Supplement Associations (IADSA) | www.iadsa.org |
| OECD Agriculture & Food | www.oecd.org/agriculture |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization